Institutional Ownership Royalty Pharma PLC (RPRX)
This table provides information about the institutional ownership of Royalty Pharma PLC (RPRX). We have compiled data on the 429 institutions that hold shares in the stock, with a total of 294 Million shares, which have been reported (via 13F filing form) to have a value of $9.57 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
39,532,770
shares
|
$1.29 Billion
0.07% of portfolio
|
Q4 2024
Reduced 3.76%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
37,354,009
shares
|
$1.22 Billion
0.02% of portfolio
|
Q4 2024
Reduced 0.61%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
23,017,561
shares
|
$750 Million
0.01% of portfolio
|
Q2 2024
Added 8.54%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
16,968,321
shares
|
$553 Million
0.79% of portfolio
|
Q4 2024
Added 42.6%
|
|
|
Baillie Gifford & CO
|
Jan 31, 2025 Q4 2024 |
14,134,516
shares
|
$461 Million
0.28% of portfolio
|
Q4 2024
Reduced 12.33%
|
|
|
Viking Global Investors LP
|
Feb 14, 2025 Q4 2024 |
12,207,885
shares
|
$398 Million
1.05% of portfolio
|
Q4 2024
Added 0.94%
|
|
|
Swedbank Ab
Stockholm, V7 |
Jan 23, 2025 Q4 2024 |
12,164,170
shares
|
$396 Million
0.39% of portfolio
|
Q4 2024
New holding
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
9,760,163
shares
|
$318 Million
0.01% of portfolio
|
Q4 2024
Added 2.56%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
7,312,551
shares
|
$238 Million
0.01% of portfolio
|
Q4 2024
Added 0.64%
|
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
4,880,346
shares
|
$159 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
3,673,200
shares
|
$120 Million
0.23% of portfolio
|
Q4 2024
Added 21.1%
|
|
|
Siguler Guff Advisers, LLC
|
Feb 15, 2023 Q4 2022 |
3,391,754
shares
|
$111 Million
64.43% of portfolio
|
Q4 2022
Reduced 49.84%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
3,330,429
shares
|
$109 Million
0.01% of portfolio
|
Q4 2024
Added 12.75%
|
|
|
Gmt Capital Corp
Atlanta, GA |
Feb 14, 2025 Q4 2024 |
3,267,700
shares
|
$106 Million
4.24% of portfolio
|
Q4 2024
Added 5.49%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
3,189,964
shares
|
$104 Million
0.03% of portfolio
|
Q4 2024
Added 36.19%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
3,131,628
shares
|
$102 Million
0.02% of portfolio
|
Q4 2024
Added 4.33%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
2,985,585
shares
|
$97.3 Million
0.01% of portfolio
|
Q4 2024
Added 46.73%
|
|
|
New South Capital Management Inc
Memphis, TN |
Feb 06, 2025 Q4 2024 |
2,957,125
shares
|
$96.4 Million
3.59% of portfolio
|
Q4 2024
Added 19.9%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
2,897,964
shares
|
$94.4 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Patient Capital Management, LLC
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
2,875,089
shares
|
$93.7 Million
3.76% of portfolio
|
Q4 2024
Added 40.85%
|
|
|
Legal & General Group PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
2,633,882
shares
|
$85.8 Million
0.02% of portfolio
|
Q4 2024
Reduced 15.38%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
2,621,886
shares
|
$85.4 Million
0.02% of portfolio
|
Q4 2024
Reduced 11.79%
|
|
|
Amundi
Paris, I0 |
Feb 07, 2025 Q4 2024 |
2,553,998
shares
|
$83.2 Million
0.02% of portfolio
|
Q4 2024
Reduced 30.81%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,420,403
shares
|
$78.9 Million
0.15% of portfolio
|
Q4 2024
Reduced 0.37%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
2,415,281
shares
|
$78.7 Million
0.03% of portfolio
|
Q4 2024
Reduced 44.37%
|